Home/Pipeline/Bone Graft Substitute

Bone Graft Substitute

Spinal Fusion

Pre-clinicalActive

Key Facts

Indication

Spinal Fusion

Phase

Pre-clinical

Status

Active

Company

BiologicsMD

About BiologicsMD

BiologicsMD is a private, preclinical-stage biotechnology company founded in 2007 and headquartered in Boca Raton, Florida. The company's core innovation is a modular fusion protein platform designed to deliver potent, localized, and long-acting therapies for conditions like alopecia and bone disorders, aiming to minimize systemic side effects. Led by a management team with significant biopharma commercialization and venture capital experience, the company is advancing multiple programs but remains pre-revenue and faces the typical high-risk, high-reward path of drug development. Its strategy hinges on validating its novel targeting approach and securing partnership or funding to advance its pipeline.

View full company profile

Therapeutic Areas

Alopecia (Hair Loss)Bone Disorders Oncology (Bone Metastases)

Other Spinal Fusion Drugs

Drug	Company	Phase	Status
JAZBI™ Cubes	SDIP Innovations	Preclinical	Active
Expandable Interbody Portfolio	Globus Medical	Iterative Development	Active
Mimetic Metal Technology Development	CoreLink Surgical	Development/Commercial	Active
VisuALIF	SpineSmith	Commercial	Active
ASTRO Registry	Artoss	Post-Market	Active
Hive Smart Implant Exploration	NanoHive Medical	Pre-clinical R&D	Active
ProLift Pivot Expandable Spacer System	Life Spine	FDA Cleared	Active
NEXXT MATRIXX Clinical Evidence Study	Nexxt Spine	Post-Market Study	Active
AGA111	Angitia Biopharmaceuticals	Phase 3	Active
X-PAC® Portfolio Expansion	Expanding Innovations	Development	Active
SOLACE™	Xenix Medical	Commercial	Active
TrellOss Porous Ti Interbody System	HighRidge Medical	Approved	Active